Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiomic Analysis Reveals Disruption of Cholesterol Homeostasis by Cannabidiol in Human Cell Lines.
Guard SE, Chapnick DA, Poss ZC, Ebmeier CC, Jacobsen J, Nemkov T, Ball KA, Webb KJ, Simpson HL, Coleman S, Bunker E, Ramirez A, Reisz JA, Sievers R, Stowell MHB, D'Alessandro A, Liu X, Old WM. Guard SE, et al. Mol Cell Proteomics. 2022 Oct;21(10):100262. doi: 10.1016/j.mcpro.2022.100262. Epub 2022 Jun 24. Mol Cell Proteomics. 2022. PMID: 35753663 Free PMC article.
Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study.
Kennelly M, Dmochowski R, Schulte-Baukloh H, Ethans K, Del Popolo G, Moore C, Jenkins B, Guard S, Zheng Y, Karsenty G; 191622-094 Investigators. Kennelly M, et al. Among authors: guard s. Neurourol Urodyn. 2017 Feb;36(2):368-375. doi: 10.1002/nau.22934. Epub 2015 Nov 24. Neurourol Urodyn. 2017. PMID: 26607743 Clinical Trial.
Efficacité et innocuité à long terme des injections répétées d'OnabotulinumtoxinA (BOTOX(®)) chez des patients souffrant d'hyperactivité du détrusor d'origine neurologique : résultats finaux d'un suivi longitudinal jusqu'à 4ans.
Karsenty G, Schulte-Baukloh H, Dmochowski R, Ethans K, Brenda J, Guard S, Zheng Y, Kennelly M. Karsenty G, et al. Among authors: guard s. Prog Urol. 2014 Nov;24(13):841. doi: 10.1016/j.purol.2014.08.128. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461654 French. No abstract available.
Le traitement par onabotulinumtoxin A (BOTOX(®)) améliore l'incontinence urinaire et la qualité de vie des patients porteurs d'hyperactivité Vésicale idiopathique indépendamment des infections urinaires ou du recours à l'autosondage.
Chartier-Kastler E, Everaert K, Gruenenfelder J, Schulte-Baukloh H, Guard S, Zheng Y, Sussman D. Chartier-Kastler E, et al. Among authors: guard s. Prog Urol. 2014 Nov;24(13):797-8. doi: 10.1016/j.purol.2014.08.036. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461561 French. No abstract available.
30 results